In fact the CEO's legacy so far over the 13 years or so is to bring the SP from just below $4 to 0.5 cents (preconsolidation) and not to 10 cents. The later value is after consolidation. Not withstanding the $45 million dollars loss to the share holders and the destruction of the biotech arm of the company. I do not know any other CEO who has survived this much incompetence.
Ann: Initial Director's Interest Notice - Eck-Thompson, page-9
Add AN1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.768M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.6¢ | $11.31K | 1.886M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1650000 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 915710 | 1 |
View Market Depth
| Last trade - 14.23pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.6¢ |
Change
0.000 ( 14.3 %) |
||||
| Open | High | Low | Volume | ||
| 0.6¢ | 0.6¢ | 0.6¢ | 287949 | ||
| Last updated 14.34pm 14/06/2024 ? | |||||
| AN1 (ASX) Chart |